Massive pulmonary thromboembolism combined with transient thyrotoxicosis in an 18 year old girl
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potentially life–threatening emergency involving a systemic hypercoagulable state. We report on an 18 year-old-girl with transient thyrotoxicosis with massive PTE without DVT. Case presentation: An 18-year-old girl was admitted to the hospital with syncope. Patient had no history of trauma, any known underlying disease or oral contraceptives use. Chest computed tomography (CT) showed massive PTE in both central pulmonary arteries and diffuse goiter. However, a low extremity Doppler sonogram did not detect DVT. To manage the PTE, we administered low molecular weight heparin. On the other hands, thyroid function test indicated a state of thyrotoxicosis. In addition, patient had a partial protein S deficiency but no other immunologic abnormality. Therefore, the patient was diagnosed with massive PTE, thyrotoxicosis, and partial protein S deficiency. Patient was discharged with oral warfarin and methimazole. A follow-up echocardiogram obtained 3 months after anticoagulation therapy demonstrated normal dimensions and systolic function. After thyrotoxicosis was treated with methimazole for a month, a euthyroid state was achieved and the goiter decreased to a normal size. The methimazole was gradually tapered off and stopped at 4 months. At a 6-month follow up visit, PTE and pulmonary hypertension had disappeared but the patient still had a partial protein S deficiency. We decided to stop all medication with careful monitoring. During a 4- year follow-up period after the episode, she was asymptomatic without any evidence of recurrent systemic thromboembolism or hyperthyroidism. Conclusions: Early recognition and appropriate treatment of PTE combined with transient thyrotoxicosis were vital to preventing other complications.
Abstract
Background: Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potentially life–threatening emergency involving a systemic hypercoagulable state. We report on an 18 year-old-girl with transient thyrotoxicosis with massive PTE without DVT. Case presentation: An 18-year-old girl was admitted to the hospital with syncope. Patient had no history of trauma, any known underlying disease or oral contraceptives use. Chest computed tomography (CT) showed massive PTE in both central pulmonary arteries and diffuse goiter. However, a low extremity Doppler sonogram did not detect DVT. To manage the PTE, we administered low molecular weight heparin. On the other hands, thyroid function test indicated a state of thyrotoxicosis. In addition, patient had a partial protein S deficiency but no other immunologic abnormality. Therefore, the patient was diagnosed with massive PTE, thyrotoxicosis, and partial protein S deficiency. Patient was discharged with oral warfarin and methimazole. A follow-up echocardiogram obtained 3 months after anticoagulation therapy demonstrated normal dimensions and systolic function. After thyrotoxicosis was treated with methimazole for a month, a euthyroid state was achieved and the goiter decreased to a normal size. The methimazole was gradually tapered off and stopped at 4 months. At a 6-month follow up visit, PTE and pulmonary hypertension had disappeared but the patient still had a partial protein S deficiency. We decided to stop all medication with careful monitoring. During a 4- year follow-up period after the episode, she was asymptomatic without any evidence of recurrent systemic thromboembolism or hyperthyroidism. Conclusions: Early recognition and appropriate treatment of PTE combined with transient thyrotoxicosis were vital to preventing other complications.
참고문헌 (9)
- Bagot CN, "Virchow and his triad : a question of attribution", Br J Haematol, 143(2), pp.180~190 (2008)
- van Langevelde K, "Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique", Haematologica, 98(2), pp.309~315 (2013)
- Nayak B, "Thyrotoxicosis and thyroid storm", Endocrinol Metab Clin N Am, 35(4), pp.663~686 (2006)
- Lodha A, "Thyrotoxicosis causing arterial and venous thrombosis", Am J Med Sci, 338(5), pp.428~ (2009)
- Stuijver DJF, "The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors. A systematic review and meta-analysis", Thromb Haemost, 108(12), pp.1077~1088 (2012)
- Elbers LPB, "The influence of thyroid function on the coagulation system and its clinical consequences", J Thromb Haemost, 16(4), pp.634~645 (2018)
- Elbers LPB, "Thyroid disorders and hemostasis", Semin Thromb Hemost, 44(7), pp.676~682 (2018)
- Debeij J, "High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis : the MEGA study", J Thromb Haemost, 12(06), pp.839~846 (2014)
- Ten Kate MK, "Protein S deficiency : a clinical perspective", Haemophilia, 14(6), pp.1222~1228 (2008)